Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors

International Journal of Gynecological Cancer

Volumn 19, Issue 3, 2009, Pages 339-342

  Bittinger, Sophie ^a,b   Alexiadis, Maria ^a   Fuller, Peter J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Southern Health Clayton ^*  (Australia)

Author keywords

Granulosa cell tumors; Ovarian cancer; PIK3; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADOLESCENT; ADULT; AGED; AMPLICON; ARTICLE; CELL LINE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME SUBUNIT; EXON; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GRANULOSA CELL TUMOR; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; PROTEIN SUBUNITS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 68149099875     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a1cdfd     Document Type: Article

References (25)

1. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180-1189.
2. Colombo N., Parma G., Zanagnoio V., et al. Management of ovarian stromal cell tumors. J Clin Oncol. 2007;25:2944-2951.
3. Fuller PJ, Chu S. Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours. Trends Endocrinol Metab. 2004;15:122-128.
4. Chu S., Rushdi S., Zumpe ET, et al. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod. 2002;8:426-433.
5. Richards JS, Russell DL, Ochsner S., et al. Novel signalling pathways that control ovarian follicular development, ovulation and luteinisation. Recent Prog Horm Res. 2002;57:195-220.
6. Campbell IG, Russell SE, Choong DYH, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 2004;64:7678-7681.
7. Qiu W., Schonleben F., Li X., et al. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12:1441-1446.
8. Philp AJ, Campbell IG, Leet C., et al. The phosphatidylinositol 3'-kinase p85> gene is an oncogene in human ovarian and colon tumours. Cancer Res. 2001;61:7426-7429.
9. Forgacs E., Biesterveld EJ, Sekido Y., et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene. 1998;17:1557-1565.
10. Vivanco I., Sawyers CL. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nature. 2002;2:489-50.
11. Chu S., Nishi YT, Nawata H., et al. Transrepression of estrogen receptor A signalling by nuclear factor-JB in ovarian granulosa cells. Mol Endocrinol. 2004;18:1919-1928.
12. Chu S., Alexiadis M., Fuller PJ. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors. Gynecol Oncol. 2008;108:182-190.
13. Fuller PJ, Chu S., Fikret S., et al. Molecular pathogenesis of granulosa cell tumours. Mol Cell Endocrinol. 2002;191:89-96.
14. Healy DL, Burger HG, Mamers P., et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med. 1993;329:1539-1542.
15. Burger HG, Fuller PJ, Chu S., et al. The inhibins and ovarian cancer. Mol Cell Endocrinol. 2001;180:145-148.
16. Hussein S., Chu S., Fuller PJ. Comment on analysis of mutations in genes of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metabol. 1999;84:3852.
17. Kalfa N., Ecochard A., Patte C., et al. Activating mutations of the stimulatory G protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab. 2005;91:1842-1847.
18. Cottom J., Salvador LM, Maizels ET, et al. Follicle-stimulating hormone activates extracellular signal-regulated kinase but not extracellular signal-regulated kinase kinase through a 100-kDa phosphotyrosine phosphatase. J Biol Chem. 2003;278:7167-7179.
19. Wang Y., Chan S., Tsang BK. Involvement of inhibitory nuclear factor-kB (NFkB) - independent NFkB activation in the gonadotropic regulation of X-linked inhibitor of apoptosis expression during ovarian follicular development in vitro. Endocrinology. 2002;143:2732-2740.
20. Steinmetz R., Wagoner HA, Zeng P., et al. Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol. 2004;18:2570-2582.
21. Jamieson S., Alexiadis M., Fuller PJ. Expression status and mutational analysis of the ras and B-raf genes in granulosa cell and epithelial tumors of the ovary. Gynecol Oncol. 2004;95:603-609.
22. Lin WM, Forgacs E., Warshal DP, et al. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin Cancer Res. 1998;4: 2577-2583.
23. Obata K., Morland SJ, Watson RH, et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 1998;58:2095-2097.
24. Kurose K., Zhou XP, Araki T., et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol. 2001;158:2097-2106.
25. Oda K., Stokoe D., Taketani Y., et al. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res. 2005;65:10669-10673.